Outcomes of recommendations by hospice pharmacists

American Journal of Health-System Pharmacy

Volumn 63, Issue 22, 2006, Pages 2235-2239

  Lee, Jerome ^a   McPherson, Mary Lynn ^b,c  

^a Walgreens Pharmacy   (United States)

^b U of WI School of Pharmacy   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Drug use; Hospices; Interventions; Outcomes; Pharmaceutical care; Pharmaceutical services; Pharmacists, consultant; Rational therapy; Toxicity

Indexed keywords

ARTICLE; ECONOMIC EVALUATION; HOSPICE; INTERRATER RELIABILITY; PALLIATIVE THERAPY; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED STATES;

EID: 33845209361     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060143     Document Type: Article

References (15)

1. World Health Organization Expert Committee. Cancer pain relief and palliative care. Technical report series 804. Geneva, Switzerland: World Health Organization; 1990.
2. American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm. 1993; 50:1720-3.
3. American Pharmaceutical Association. Clinical evidence of the value of pharmacists. www.aphanet.org/pharmcare/ clinicalsumm.html (accessed 2003 Sep 4).
4. Schumock G, Meek P, Ploetz P et al. Economic evaluations of clinical pharmacy services: 1988-1995. Pharmacotherapy. 1996; 16:1188-208.
5. Schumock G, Butler M, Meek P et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003; 23:113-32.
6. Needham D. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. Palliat Med. 2002; 16:219-25.
7. Scarsi K, Fotis M, Noskin G. Pharmacist participation in medical rounds reduces medication errors. Am J Health-Syst Pharm. 2002; 59:2089-92.
8. Mutnick A, Sterba K, Peroutka J et al. Cost savings and avoidance from clinical interventions. Am J Health-Syst Pharm. 1997; 54:392-6.
9. Lucas C, Glare P, Sykes J. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit. Palliat Med. 1997; 11:209-16.
10. Austwick E, Brown L, Goodyear K et al. Pharmacist's input into palliative care clinic. Pharm J. 2002; 268:404-6.
11. Overhage J, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities. Am J Health-Syst Pharm. 1999; 56:2444-50.
12. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960; 20:37-46.
13. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977; 33:159-74.
14. Feinstein A, Cicchetti D. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990; 43:543-9.
15. Feinstein A, Cicchetti D. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol. 1990; 43:551-8.